Addition of rituximab to chop does not increase the risk of...

Medical Oncology 2008 / 12 Vol. 25; Iss. 4

Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin’s lymphoma

Saadettin Kilickap, Bunyamin Yavuz, Sercan Aksoy, Levent Sahiner, Murat Dincer, Hakan Harputluoglu, Mustafa Erman, Kudret Aytemir, Lale Tokgozoglu, Ibrahim Barista
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
25
Language:
english
Pages:
6
DOI:
10.1007/s12032-008-9062-2
Date:
December, 2008
File:
PDF, 155 KB
english, 2008
Conversion to is in progress
Conversion to is failed